Ventures Llc Amgen, 10% Owner at Epizyme, Inc. (EPZM), bought 334,126 shares at $15.00 ($250K) on 2013-06-05, disclosed to the SEC on 2013-06-05.
Open-market purchase of $250k EPZM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 317,460 | $0 | 0.0% |
| 2 | $15.00 | 16,666 | $250K | 100.0% |
| Total | $0.75 avg | 334,126 | $250K | 100% |